期刊文献+

阻断B7-H1通路增强膀胱癌患者外周血树突状细胞免疫功能的实验研究

Experimental study on enhancement of immune function of dendritic cells from peripheral blood of patients with bladder cancer by blocking the B7-H1 pathway
原文传递
导出
摘要 目的:探讨膀胱癌患者外周血与正常人外周血树突状细胞(DCs)免疫功能的差异以及B7-H1阻断对膀胱癌患者外周血DCs免疫功能的影响。方法:采集膀胱癌患者及正常人的外周血,用rhGM-CSF、rhIL-4和rhTNF-α自外周血单个核细胞(PBMC)诱导分离DCs,混合淋巴细胞反应检测DCs刺激淋巴细胞增殖的能力。然后于膀胱癌DCs组加入B7-H1的阻断型抗体,混合淋巴细胞反应检测B7-H1阻断后DCs刺激淋巴细胞增殖的能力,ELISA法检测阻断后DCs分泌IL-10和IL-12的水平。结果:膀胱癌患者外周血DCs刺激淋巴细胞增殖的能力低于正常人外周血DCs,而加入B7-H1阻断型抗体阻断B7-H1后,膀胱癌患者外周血DCs刺激淋巴细胞增殖的能力得到明显提高,同时其分泌IL-10水平明显降低,而分泌IL-12水平明显增加。结论:膀胱癌患者外周血DCs存在免疫功能缺陷,其机制可能与DCs表面B7-H1的诱导高表达有关,而B7-H1阻断能够增强膀胱癌患者外周血DCs的免疫功能。 Objective: To explore the differences of dendritic cells (DCs) in peripheral blood between patients with bladder cancer and normal human, and to investigate the effects of B7-H1 blockade on the immune function of DCs in peripheral blood of patients with bladder cancer. Method: DCs were induced by stimulation of patients with bladder cancer and normal human peripheral blood mononuclear cells (PBMC) with rhGM-CSF, rhIL-4 and rhT- NF-a. Then the DCs in peripheral blood of patients with bladder cancer were cultured with anti-B7-H1 mAbs to block B7-H1 pathway. The proliferation efficiency of DCs was measured by mixed lymphocyte reaction and the concentration of IL-10 and IL-12 were measured by ELISA method. Result: The proliferation efficiency of DCs was lower in patient group than in healthy group. Blockade of BT-H1 promoted the proliferation of DCs and enhanced iL-12 secretion but suppressed IL-10 secretion. Conclusion: Immune dysfunction exists in DCs in peripheral blood of patients with bladder cancer. The mechanism may be associated with high expression of B7-H1 on circulating DCs, whereas blockade of B7-H1 can enhance immune function of DCs in peripheral blood of patients with bladder cancer.
出处 《临床泌尿外科杂志》 2014年第5期429-431,共3页 Journal of Clinical Urology
基金 国家自然科学基金青年科学基金项目(编号81101932)
关键词 膀胱肿瘤 B7-H1 树突状细胞 免疫逃逸 bladder cancer B7-H1 dendritic cells immune escape
  • 相关文献

参考文献3

二级参考文献50

  • 1李德春,朱兴国,张勇,傅建新.共刺激分子CD80基因转染对肝癌细胞恶性表型的影响[J].中华实验外科杂志,2004,21(9):1146-1146. 被引量:1
  • 2Dong H, Strome SE, Salomao DR, et al. Tumor-associated BT-HI promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med,2002,8:793-800.
  • 3Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immuno1,2007,19:813-824.
  • 4Pardoll D.Does the immune system see tumors as foreign or self? Annu Rev Immunol 2003; 21:807-839.
  • 5Rabinovich GA,Gabrilovich D,Sotomayor EM.Immunosuppressive strategies that are mediated by tumor cells.Annu Rev Immunol 2007; 25:267-296.
  • 6Gabrilovich DI,Nagaraj S.Myeloid-derived suppressor cells as regulators of the immune system.Nat Rev Immunol 2009; 9: 162-174.
  • 7Li X,Kostareli E,Suffner J,Garbi N,H mmerling GJ.Efficient Treg depletion induces T-cell infiltration and rejection of large tumors.Eur J Immunol 2010; 40:3325-3335.
  • 8Poehlein CH,Haley DP,Walker EB,Fox BA.Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific,therapeutic effector T cells in lymphopenic hosts.Eur J Immunol 2009; 39:3121-3133.
  • 9Yuan XL,Chen L,Li MX,Dong P,Xue J,Wang J,Zhang TT, Wang XA,Zhang FM,Ge HL,Shen LS,Xu D.Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.Clin Immunol 2010; 134: 277-288.
  • 10Antony PA,Piccirillo CA,Akpinarli A,Finkelstein SE,Speiss PJ,Surman DR,Palmer DC,Chan CC,Klebanoff CA,Overwijk WW,Rosenberg SA,Restifo NP.CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.J Immunol 2005; 174:2591-2601.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部